Integrin receptor antagonist GLPG-0187 inhibits metastatic tumor growth and bone tumor burden Sep. 17, 2009
Long-term effects, cardiac safety and cognitive improvement assessed with fampridine-SR Sep. 16, 2009
Fatty acid synthase inhibitor UCM-Gi028 developed for anti-HER resistant cancer therapy Sep. 16, 2009